-
10 Sep 2024Xellia Pharmaceuticals announces the completion of the divestment of its US-based institutional activities to ...Read article
-
17 Jun 2024Xellia Pharmaceuticals to focus on the manufacturing and commercialization of its life-saving anti-infectives ...Read article
-
29 Apr 2024US Court Lifts Modified Consent Decree Entered into by FDA and Xellia’s Cleveland FacilityRead article
-
29 Nov 2023Xellia starts commercial production and distribution of premix bag products from its Cleveland facilityRead article
-
06 Nov 2023Xellia Celebrates World Quality Week 2023Read article
-
02 Oct 2023Xellia Pharmaceuticals welcomes Michael Kocher as its new Chief Executive OfficerRead article
-
29 Sep 2023Xellia Pharmaceuticals successfully finalizes all activities related to the Industrial Research and Innovation...Read article
-
14 Jun 2023Xellia Pharmaceuticals announces the appointment of Michael Kocher as its new Chief Executive OfficerRead article
-
01 Jun 2023Celebrating Diversity and InclusionRead article
-
18 Apr 2023Xellia Pharmaceuticals Reports 2022 Business Update and 2023 OutlookRead article
-
04 Apr 2023SOS Children’s Villages and Xellia Pharmaceuticals End Year Report 2022 complemented by ‘Xellia visits SOS Chi...Read article
-
18 Jan 2023Xellia Pharmaceuticals appoints Hanne Junggreen as Corporate Vice President of Global QualityRead article
-
18 Jan 2023Xellia Pharmaceuticals appoints John Stewart as Senior Vice President of Global Product SupplyRead article
-
16 Dec 2022Xellia Pharmaceuticals Joins End Drug Shortages AllianceRead article
-
08 Dec 2022Xellia Pharmaceuticals secures $430m financing to support long-term growthRead article
-
07 Nov 2022Celebrating World Quality Week 2022Read article
-
27 Oct 2022Xellia in the news, Berlingske Media Life Science EditionRead article
-
27 Sep 2022Xellia Pharmaceuticals Joins the Pharmaceutical Supply Chain Initiative to Promote focus on Responsible Supply...Read article
-
13 Sep 2022Surviving Sepsis: Importance of Timely Antibiotic Administration – A whitepaper sponsored by Xellia Pharmaceut...Read article
-
15 Aug 2022Celebrating Diversity Inclusion & BelongingRead article
-
25 Jul 2022The Impact of Pre-mix Intravenous Medication in the Pharmacy - A study by Virginia Mason Institute (VMI) spons...Read article
-
27 Jun 2022Xellia Pharmaceuticals USA, LLC, Receives Supplier Horizon Award from Premier Inc.Read article
-
25 Apr 2022Xellia Pharmaceuticals Reports 2021 Business Update and 2022 OutlookRead article
-
17 Aug 2021Xellia Pharmaceuticals Cleveland, Ohio manufacturing facility commercially operational for production of key a...Read article
-
21 Jun 2021Xellia Pharmaceuticals globally certified as a Great Place to Work® following company-wide employee surveyRead article
-
28 Apr 2021Xellia Pharmaceuticals receives Industrial Research and Innovation (IRI) Grant to support the development of V...Read article
-
22 Apr 2021Celebrating Earth Day 2021!Read article
-
19 Apr 2021Xellia in the news, Berlingske Media Life Science Edition - Fighting the Slow PandemicRead article
-
15 Apr 2021Xellia has signed the UN Women’s Empowerment PrinciplesRead article
-
22 Mar 2021Xellia Pharmaceuticals appoints Preben Haaning to its Board of DirectorsRead article
-
08 Mar 2021Xellia Pharmaceuticals appoints Patrick Brunner as Vice President North America Manufacturing Operations and n...Read article
-
09 Feb 2021Xellia Pharmaceuticals announces a new three-year collaboration agreement with SOS Children’s Villages, Denmar...Read article
-
21 Jan 2021Xellia Pharmaceuticals joins Medicines for Europe to support better access to critical medicinesRead article
-
01 Dec 2020SOS Talk: Carl-Åke Carlsson, CEO & President of Xellia Pharmaceuticals, and Marianne Norup-Nielsen, Senior Dir...Read article
-
18 Nov 2020Xellia joins World Antimicrobial Awareness Week on 18-24 November 2020Read article
-
12 Nov 2020Xellia celebrates World Quality Day on November 12th 2020Read article
-
29 Sep 2020Xellia Pharmaceuticals demonstrates commitment to the fight against sepsis by providing support for Sepsis Awa...Read article
-
08 Sep 2020Podcast: Molecule to Market featuring Carl-Åke Carlsson, CEO & President Xellia PharmaceuticalsRead article
-
24 Aug 2020The release of Xellia’s global recruitment film: Our Culture, Our Values, Our Purpose – Being an Xellian | Glo...Read article
-
02 Jul 2020Xellia's response to the COVID-19 outbreakRead article
-
19 Jun 2020Xellia Pharmaceuticals Opens New Commercial Office in DubaiRead article
-
12 May 2020Xellia Pharmaceuticals recruiting additional >100 employees to expand workforce at its Cleveland, Ohio manufac...Read article
-
21 Apr 2020The release of Xellia’s corporate film: Our Journey, Building for the Future.Read article
-
01 Apr 2020Xellia Pharmaceuticals Reports Strong Full Year Results for 2019 and Provides Key Business UpdatesRead article
-
26 Mar 2020Xellia Pharmaceuticals' site, Cleveland, Ohio, passes FDA inspection of Injectable Drug Manufacturing Methods,...Read article
-
19 Mar 2020Xellia's response to the COVID-19 outbreakRead article
-
12 Mar 2020Xellia’s response to the COVID-19 outbreakRead article
-
11 Sep 2019Xellia Pharmaceuticals appoints Peter Baker as Chief Commercial Officer, Xellia North AmericaRead article
-
01 Mar 2019Xellia Pharmaceuticals Divests Raleigh, North Carolina Production Facilities to Sagent PharmaceuticalsRead article
-
14 Jan 2019Xellia Pharmaceuticals welcomes HRH Princess Benedikte of Denmark to its Copenhagen SiteRead article
-
03 Jan 2019Xellia Pharmaceuticals Appoints Barbara Purcell to its Board of DirectorsRead article
-
18 Sep 2018Xellia Pharmaceuticals Opens North American Commercial Office in ChicagoRead article
-
06 Sep 2018LEUKOCARE and Xellia Pharmaceuticals partner to discover innovative formulationsRead article
-
13 Jun 2018Xellia Pharmaceuticals Appoints Matthew Anderson as Chief Financial OfficerRead article
-
23 Apr 2018Xellia Pharmaceuticals Appoints Craig Boyd as President, Xellia US as it Expands its Commercial OrganizationRead article
-
21 Mar 2018Xellia Pharmaceuticals Reports on Strong 2017 Financial Results and Advances in the Development of its Novel P...Read article
-
14 Nov 2017Xellia Pharmaceuticals Welcomes VIPs from across Ohio as it prepares for Full Scale Manufacturing and Continue...Read article
-
11 Oct 2017Xellia Pharmaceuticals Expands its Global Specialty Anti-infective Product Manufacturing Capabilities with a U...Read article
-
18 Sep 2017The Xellia SOS Children’s Villages’ Medical Center ReportRead article
-
08 Aug 2017Xellia Pharmaceuticals Completes Expansion of its Budapest Facilities, Strengthening its Global Anti-infective...Read article
-
24 Apr 2017Publication in Acquisition International: A Manufacturing 'One-Stop-Shop'Read article
-
30 Mar 2017Publication in Pharma Horizon: Five minutes at DCAT with Carl-Åke CarlssonRead article
-
23 Mar 2017Publication in Life Science Leader: Why Xellia Revived a Shuttered PharmaRead article
-
23 Mar 2017Publication in S&P Global Market Intelligence: Small companies play big role in search for superbug killersRead article
-
10 Mar 2017Publication in the Danish magazine Optimering: Xellia's Focus on Energy ConsumptionRead article
-
07 Feb 2017Xellia Pharmaceuticals’ Increased Revenue by 17% in 2016Read article
-
18 Jan 2017Xellia Pharmaceuticals Signs Davos Declaration on Combating Antimicrobial ResistanceRead article
-
14 Nov 2016Xellia Pharmaceuticals Commences Packaging and Distribution Operations at Cleveland Site after Successful FDA ...Read article
-
27 Sep 2016Xellia Pharmaceuticals Expands Croatian Anti-Infective Product and Innovation Capabilities to Tackle Antimicro...Read article
-
31 May 2016Xellia Pharmaceuticals Welcomes Dignitaries from Hungarian Ministry of Foreign Affairs and Trade and Hungarian...Read article
-
25 May 2016Xellia Pharmaceuticals Expands Budapest Facilities to Strengthen Anti-infective Product CapabilitiesRead article
-
29 Apr 2016Xellia Pharmaceuticals Full Year Results for the year ended 31 December 2015Read article
-
25 Apr 2016Xellia Pharmaceuticals Reaches Agreement with FDA on Modifications to Consent Decree for Newly-Acquired Clevel...Read article
-
25 Nov 2015Xellia Pharmaceuticals Expands US Production with Acquisition of Manufacturing Plant from Hikma Pharmaceutical...Read article
-
13 Aug 2015Xellia Pharmaceuticals Expands Raleigh, NC Site to Become New North American HeadquartersRead article
-
17 Dec 2014Xellia Pharmaceuticals Focuses on Innovation in Anti-infectives with Formation of Scientific Advisory BoardRead article
-
18 Nov 2014On European Antibiotic Awareness Day Xellia Pharmaceuticals Strengthens Commitment to Innovation in Anti-Infec...Read article
-
23 Oct 2014Xellia Pharmaceuticals Welcomes HM the Queen of Denmark to Zagreb R&D Center of Excellence During State Visit ...Read article
-
15 Sep 2014Xellia Pharmaceuticals Seeks New Talent as it Expands Manufacturing Facility in Raleigh, NCRead article
-
01 Sep 2014Xellia Pharmaceuticals Appoints Mads Bodenhoff as New Chief Financial Officer and Vice PresidentRead article
-
07 Jul 2014Xellia Pharmaceuticals Expands into the US with Acquisition of Manufacturing PlantRead article
-
15 May 2014Xellia Pharmaceuticals Expands Croatian Product and Innovation R&D Centre of Excellence with Investment of US$...Read article
-
11 Nov 2013Xellia Pharmaceuticals Appoints New Chairman and Board MembersRead article
-
21 May 2013Novo AS acquires Xellia PharmaceuticalsRead article
-
25 Feb 2013Xellia Enters 4 Year Collaboration to Develop New Antibiotics to Combat Multi-Drug Resistant BacteriaRead article
